Navigation Links
Nuvo announces second quarter 2008 financial results
Date:7/31/2008

30, 2008, compared to $1.3 million and $2.8 million for the three and six-months ended June 30, 2007. The decrease is primarily attributable to activities undertaken during the third and fourth quarters of 2007 including the closure of the Company's international marketing office in Barbados and staff reductions at the corporate head office.

For the three-months ended June 30, 2008 the net loss declined slightly to $2.9 million from $3.0 million for the three-months ended June 30, 2007. The Company was able to reduce the net loss as higher research and development expenditures and foreign exchange losses were more than offset by the increased gross margin generated from higher product sales and a reduction in SG&A costs. For the six-months ended June 30, 2008 the net loss declined by 21% to $5.1 million from $6.5 million for the six-months ended June 30, 2007.

Cash used in operations was $2.6 million for the three-months ended June 30, 2008 compared to $2.8 million for the three-months ended June 30, 2007. The decrease of 9% was primarily the result of the reduced net loss during the quarter. Overall, cash used in operating activities decreased to $2.3 million for the three-months ended June 30, 2008 versus $3.5 million for the three-months ended June 30, 2007 as the Company's investment in non-cash working capital improved significantly. For the six-month period ended June 30, 2008 funds used in operating activities decreased to $5.2 million from $6.5 million for the six-month period ended June 30, 2007 primarily due to the smaller loss in the period.

Net cash used in investing activities totaled $57,000 and $56,000 for the three and six-months ended June 30, 2008 compared with $189,000 for both the three and six-months ended June 30, 2007. The investment in the quarter relates to the acquisition of a new data management and biostatistics computer system. The Company also invested $191,000 in new laboratory equipment during the quarter at its S
'/>"/>

SOURCE Nuvo Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
2. Cardiva Medical Announces Presentation at BMO Capital Markets 2008 Focus on Healthcare Conference
3. Lyriana Announces Antidepressants Now Linked to Declining Libido in Women
4. Hologic Announces Third Quarter Fiscal 2008 Operating Results
5. VendorClear™ Announces Limited Release of New Products for Healthcare Facilities and Vendor Representatives
6. The Quantum Group Announces 2nd Statewide Contract
7. STERIS Corporation Announces Fiscal 2009 First Quarter Results
8. CutisPharma Announces Strategic Collaboration with Rite Aid Corporation
9. Cell Therapeutics, Inc. Announces $12 Million Equity Line of Credit
10. BrainLAB Announces 510(k) FDA Clearance of Monte Carlo Dose Engine for Stereotactic Radiosurgery and Radiation Therapy
11. Align Technology Announces Second Quarter Fiscal 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... 06, 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a ... at a CAGR of over 3.2 percent in the years to come to hit ... mainly spurred by an anticipated launch of a number of promising pipeline candidates and ...
(Date:7/6/2015)... ... July 06, 2015 , ... Cancer Hope Network (CHN) ... and medical professionals to chat with the CHN patient services team and connect ... cancer diagnosis is often the most traumatic experience of a person’s life,” said ...
(Date:7/6/2015)... Oakland, CA (PRWEB) , ... July 06, 2015 , ... ... Adults can learn how to reduce their risk of having a fracture through the ... Freedom From Fractures Awareness Day. , “We are participating because our residents need this ...
(Date:7/6/2015)... ... July 06, 2015 , ... Promero, a leading cloud hosting ... Unified IP contact center solution hosted by Promero. Randstad Technologies,a leading talent ... future call center platform. , Promero will implement and manage the private ...
(Date:7/5/2015)... Minneapolis, MN (PRWEB) , ... July 06, 2015 ... ... in the ancillary benefits market, is excited to announce the next generation of ... Plus and Advantage plans to now include two network options—Maximum Allowable Charge (MAC) ...
Breaking Medicine News(10 mins):Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:National Bone Health Screening and Awareness Day 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... years quadrupled chance of hip breaks, study finds , , MONDAY, ... long-term use of proton pump inhibitors for acid reflux, peptic ... , This is now the third large study finding ... these medications. This latest study, reported in the current issue ...
... 11 Fort Dodge,Animal Health, a division of Wyeth ... dog owners, section on http://www.leptoinfo.com, a Web ... pet owners about,Leptospirosis, a growing canine health threat., ... animal,species and humans that occurs in countries around the ...
... Innovations,Inc. (Nasdaq: SNCI ), the only U.S.-based ... that Paul R. Wennerholm has joined,the company as ... was previously with Patterson Companies, Inc., a $3.6,billion ... the world. Wennerholm has held several positions of ...
... people aren,t getting enough of the sunlight-sourced nutrient, researchers say, ... D could increase your risk of death by 26 percent, ... not getting enough vitamin D, which the skin makes naturally ... percent of men and 53 percent of women in the ...
... food outlets, few sidewalks, and no parks? If yes, ... be physically active and placing you at increased risk ... Portland, Oregon by scientists at Oregon Research Institute (ORI), ... fast-food outlets were more likely to have residents who ...
... Cancer - The Number One ... DENVER, Aug. 11 Dogster.com, the world,s most popular,and ... dogs has,joined Morris Animal Foundation (MAF) http://www.morrisanimalfoundation.org ,in its ... will donate,$2 for every new subscription or subscription extension, through ...
Cached Medicine News:Health News:Powerful Antacid Drugs Raise Fracture Risk 2Health News:Powerful Antacid Drugs Raise Fracture Risk 3Health News:Fort Dodge Animal Health Announces Leptoinfo.com Now Available to Dog Owners 2Health News:Sonic Innovations Appoints New President and COO 2Health News:Sonic Innovations Appoints New President and COO 3Health News:Lack of Vitamin D Boosts Death Risk 2Health News:Lack of Vitamin D Boosts Death Risk 3Health News:Scientists measure connection between the built environment and obesity in baby boomers 2Health News:Dogster.com Teams With Morris Animal Foundation to Cure Canine Cancer, While Helping Dogs Suffering From Cancer Today - Makes $2 Donation for Each Subscription 2
(Date:7/6/2015)... PARK, Calif. , July 6, 2015  Protiviti, ... its 2015 Internal Auditing around the World ... Protiviti has analyzed and reported on the evolution of ... companies from around the globe as a means to ... deeper understanding of this strategic business function. ...
(Date:7/6/2015)... July 6, 2015 E-QURE Corp (OTCQB: EQUR), ... live at VirtualInvestorConferences.com on July 9, 2015. ... http://tinyurl.com/e-qure-presentation This will be a ... ask the company questions in real-time - both in ... trade booth." If attendees are not able to join ...
(Date:7/6/2015)... BOULDER, Colo. , July 6, 2015 /PRNewswire/ ... inhibitor, encorafenib, was showcased this past weekend at ... during an oral presentation.  At the meeting, data ... preliminary data from a 100-patient randomized Phase 2 ... encorafenib and cetuximab, an EGFR inhibitor, with or ...
Breaking Medicine Technology:New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4
... (Nasdaq: BIOD ) announced today that it will be ... JMP Securities Healthcare Conference, September 28, 2010 at 12:00 pm Eastern ... Interested parties can access a link to the live webcast of ... website www.biodel.com . Replays of the presentation will be available ...
... today announced that six-month follow-up clinical trial data ... the company,s Genous Bio-engineered R stent in combination ... de novo coronary artery disease. The data were ... Germany, principal investigator of the study, in the ...
Cached Medicine Technology:OrbusNeich's Genous™ Bio-engineered R stent™ Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease 2OrbusNeich's Genous™ Bio-engineered R stent™ Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease 3
... The HAAG-STREIT OM 900 Ophthalmometer uses a ... three requirements of Helmholtz: 1. The size ... the distance between the Ophthalmometer and the ... independent of the distance between the Ophthalmometer ...
... complete image capture and management application that ... leading ophthalmic clinicians, ophthalmic photographers and optometrists ... securely document the eye via the slit ... slit lamps equipped with digital or video ...
Advanced Corneal Topography System with integrated Keratometer. Keratometric and topographic measurements all in one instrument....
The Haag-Streit 81 D lens is a powerful tool for biomicroscopy as well as laser treatment of the fundus. Due to its asymmetric configuration it provides better observation parameters combined with im...
Medicine Products: